Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 401–500 of 1,027

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 302
Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes
Yokoshiki, H., Katsube, Y., Sunagawa, M., & Sperelakis, N. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01108-4 · Cited by 302
The economic burden of heart failure
O'Connell, J. B. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231503 · Cited by 302
Tissue angiotensin system in cardiovascular medicine. A paradigm shift?
Dzau, V. J., & Ré, R. N. (1994) · Circulation · doi:10.1161/01.cir.89.1.493 · Cited by 301
Health Status Identifies Heart Failure Outpatients at Risk for Hospitalization or Death
Heidenreich, P. A., Spertus, J. A., Jones, P. G., Weintraub, W. S., Rumsfeld, J. S., Rathore, S. S., Peterson, E. D., Masoudi, F. A., Krumholz, H. M., Havranek, E. P., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.021 · Cited by 300
Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J. R., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.022 · Cited by 300
Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence
Ehrlich, J. R., Hohnloser, S. H., & Nattel, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi668 · Cited by 300
Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium
Hasenfuss, G. P., Pieske, B. M., Castell, M., Kretschmann, B., Maier, L. S., & Just, H. (1998) · Circulation · doi:10.1161/01.cir.98.20.2141 · Cited by 300
First-in-man safety evaluation of renal denervation for chronic systolic heart failure: Primary outcome from REACH-Pilot study
Davies, J. E., Manisty, C., Petraco, R., Barron, A., Unsworth, B., Mayet, J., Hamady, M., Hughes, A. D., Sever, P., Sobotka, P. A., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.019 · Cited by 299
Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study
Ceremuzyński, L., Kleczar, E., Krzemińska‐Pakuła, M., Kuch, J., Nartowicz, E., Smielak-Korombel, J., Dyduszyński, A., Maciejewicz, J., Zaleska, T., Lazarczyk-Kedzia, E., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90357-s · Cited by 299
Cell therapy for cardiac repair—lessons from clinical trials
Behfar, A., Crespo‐Diaz, R. J., Terzic, A., & Gersh, B. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.9 · Cited by 298
The genetic basis of variability in drug responses
Roden, D. M., & George, A. L. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd705 · Cited by 297
A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study
Holubarsch, C., Rohrbach, M., Karrasch, M., Boehm, E., Poloński, L., Ponikowski, P. P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 295
Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure
Katz, S. D., Balidemaj, K., Homma, S., Wu, H., Wang, J., & Maybaum, S. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00790-7 · Cited by 295
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I. F., von Haehling, S., Okonko, D. O., Leyva, F., Proudler, A. J., Coats, A. J. S., & Anker, S. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.093 · Cited by 294
Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure
Kihara, T., Biro, S., Imamura, M., Yoshifuku, S., Takasaki, K., Ikeda, Y., Otuji, Y., Minagoe, S., Toyama, Y., & Tei, C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01824-1 · Cited by 294
Decreasing one-year mortality and hospitalization rates for heart failure in Sweden Data from the Swedish Hospital Discharge Registry 1988 to 2000
Schaufelberger, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.012 · Cited by 293
Outcomes After Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Markedly Reduced Left Ventricular Function
Chaliki, H. P., Mohty, D., Aviérinos, J.-F., Scott, C. G., Schaff, H. V., Tajik, A. J., & Enriquez-Sarano, M. L. (2002) · Circulation · doi:10.1161/01.cir.0000038498.59829.38 · Cited by 289
Losartan in Heart Failure
Crozier, I., Ikram, H., Awan, N. A., Cleland, J. G. F., Stephen, N., Dickstein, K., Frey, M., Young, J. B., Klinger, G. H., Makris, L., et al. (1995) · Circulation · doi:10.1161/01.cir.91.3.691 · Cited by 288
Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
Shankar, S. M., Marina, N. M., Hudson, M. M., Hodgson, D. C., Adams, M. J., Landier, W., Bhatia, R., Meeske, K., Chen, M. H., Kinahan, K. E., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-0575 · Cited by 286
Reliability of reporting left ventricular systolic function by echocardiography: A systematic review of 3 methods
McGowan, J., & Cleland, J. G. F. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00248-5 · Cited by 285
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
Heart Failure Society of America (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.04.005 · Cited by 284
A story of maladies, misconceptions and mishaps: effective management of heart failure
Horowitz, C. R., Rein, S. B., & Leventhal, H. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(03)00232-6 · Cited by 282
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy
Siepen, F. A. D., Buss, S. J., Messroghli, D., Andre, F., Loßnitzer, D., Seitz, S. A., Keller, M., Schnabel, P. A., Giannitsis, E., Korosoglou, G., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu183 · Cited by 281
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy∗∗∗∗A list of participating hospitals, central agencies and personnel appears in reference 26.
Quiñones, M. A., Greenberg, B., Kopelen, H. A., Koilpillai, C. J., Limacher, M. C., Shindler, D. M., Shelton, B. J., & Weiner, D. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00511-8 · Cited by 280
Task force 3: Recipient guidelines/prioritization
Mudge, G. H., Goldstein, S., Addonizio, L. J., Caplan, A. L., MANCINI, D. M., Levine, T. B., Ritsch, M. E., & Stevenson, L. W. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90812-f · Cited by 279
Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure
Chua, T. P., Clark, A. I., Amadi, A. A., & Coats, A. J. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00523-4 · Cited by 279
Survival after aortic valve replacement forsevere aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction
Pereira, J. J., Lauer, M. S., Bashir, M. W., Afridi, I., Blackstone, E. H., Stewart, W. J., McCarthy, P. M., Thomas, J. D., & Asher, C. R. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01759-x · Cited by 278
The role of plaque rupture and thrombosis in coronary artery disease
Zaman, A., Helft, G., Worthley, S. G., & Badimón, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00479-7 · Cited by 278
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study
Packer, M., McMurray, J. J. V., Massie, B. M., Caspi, A., Charlon, V., Solal, A. C., Kiowski, W., Kostuk, W. J., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 277
Independent and Incremental Prognostic Value of Doppler-Derived Mitral Deceleration Time of Early Filling in Both Symptomatic and Asymptomatic Patients With Left Ventricular Dysfunction
Giannuzzi, P., Temporelli, P. L., Bosimini, E., Silva, P., Imparato, A., Corrà, U., Galli, M., & Giordano, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00163-5 · Cited by 276
Hypertension and Heart Failure
Slivnick, J. A., & Lampert, B. C. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.06.007 · Cited by 275
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 275
Prolonged Beneficial Effects of a Home-Based Intervention on Unplanned Readmissions and Mortality Among Patients With Congestive Heart Failure
Stewart, S., Vandenbroek, A. J., Pearson, S., & Horowitz, J. D. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.257 · Cited by 275
Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure.
Bonneux, L., Barendregt, J. J., Meeter, K., Bonsel, G. J., & van der Maas, P. J. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.1.20 · Cited by 275
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Backer, G. D., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 273
Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) Trial
Al-Khadra, A. S., Salem, D. N., Rand, W. M., Udelson, J. E., Smith, J. J., & Konstam, M. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00502-0 · Cited by 272
Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure
Suskin, N. (2000) · European Heart Journal · doi:10.1053/euhj.1999.2043 · Cited by 271
Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart Failure
MYERS, J. N., Gullestad, L. L., Vagelos, R. H., Do, D., Bellin, D., Ross, H. J., & Fowler, M. B. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-4-199808150-00004 · Cited by 271
Echocardiography in Heart Failure
Kirkpatrick, J. N., Vannan, M. A., Narula, J., & Lang, R. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.048 · Cited by 271
Comparison and reproducibility of visual echocardiographic and quantitative radionyclide left ventricular ejection fractions
van Royen, N., Jaffe, C. C., Krumholz, H. M., Johnson, K. M., Lynch, P. J., Natale, D., Atkinson, P., Demon, P., & Wackers, F. J. T. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89179-5 · Cited by 270
Treatment of Hypertension in Patients With Coronary Artery Disease
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000207 · Cited by 269
Potassium channel down-regulation in heart failure
Näbauer, M. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00274-5 · Cited by 269
Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart Failure
Fonarow, G. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1493 · Cited by 268
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
Bristow, M. R., O’Connell, J. B., Gilbert, E. M., French, W. J., Leatherman, G. F., Kantrowitz, N. E., Orie, J. E., Smucker, M. L., Marshall, G., & Kelly, P. (1994) · Circulation · doi:10.1161/01.cir.89.4.1632 · Cited by 268
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.
Brink, M., Wellen, J. J., & Delafontaine, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118698 · Cited by 266
I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes
de Albuquerque, D. C., Neto, J. D. D. S., Bacal, F., Rohde, L., Bernardez‐Pereira, S., Berwanger, O. B., & Almeida, D. R. (2015) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20150031 · Cited by 266
Bundle Branch Reentrant Ventricular Tachycardia:
Blanck, Z., Dhala, A. A., Deshpande, S., Sra, J. S., Jazayeri, M., & Akhtar, M. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01228.x · Cited by 265
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
Afridi, I., Grayburn, P. A., Panza, J. A., Oh, J. K., Zoghbi, W. A., & Marwick, T. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00321-0 · Cited by 264
Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction
DOMANSKI, M. J., Mitchell, G. F., Norman, J. E., Exner, D. V., Pitt, B., & Pfeffer, M. A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00679-2 · Cited by 262
Socioeconomic status as an independent risk factor for hospital readmission for heart failure
Philbin, E. F., Dec, G. W., Jenkins, P., & DiSalvo, T. G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01554-5 · Cited by 262
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data
Dzau, V. J., Bernstein, K. E., Celermajer, D. S., Cohen, J. D., Dahlöf, B., Deanfield, J. E., Díez, J., Drexler, H., Ferrari, R., van Gilst, W. H., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01878-1 · Cited by 262
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging
Mark, P. B., Johnston, N., Groenning, B. A., Foster, J. E., Blyth, K. G., Martin, T. N., Steedman, T., Dargie, H. J., & Jardine, A. G. (2006) · Kidney International · doi:10.1038/sj.ki.5000249 · Cited by 261
Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction
Grigioni, F., Détaint, D., Aviérinos, J.-F., Scott, C. G., Tajik, J. A., & Enriquez-Sarano, M. L. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.030 · Cited by 261
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
McDonagh, T. A., Cunningham, A. D., Morrison, C. E., McMurray, J. J. V., Ford, I., Morton, J. J., & Dargie, H. J. (2001) · Heart · doi:10.1136/heart.86.1.21 · Cited by 261
Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials
Faris, R., Flather, M., Purcell, H., Henein, M., Poole-Wilson, P., & Coats, A. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00600-3 · Cited by 260
European Society of Cardiology Heart Failure Association Standards for Delivering Heart Failure Care
McDonagh, T. A., Blue, L., Clark, A. L., Dahlström, U., Ekman, I., Lainščak, M., McDonald, K., Ryder, M., Strömberg, A., & Jaarsma, T. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq221 · Cited by 260
Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data
Philbin, E. F., & DiSalvo, T. G. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00059-5 · Cited by 259
Task force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management
Califf, R. M., Armstrong, P. W., Carver, J. R., D’Agostino, R. B., & Strauss, W. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)87733-3 · Cited by 257
Angiotensin II, adhesion, and cardiac fibrosis
Schnee, J. M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00044-4 · Cited by 256
Anemia as a risk factor and therapeutic target in heart failure
Felker, G. M., Adams, K. F., Gattis, W. A., & O'Connor, C. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.070 · Cited by 255
Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
Lee, D. S. (2005) · JAMA · doi:10.1001/jama.294.10.1240 · Cited by 255
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
Kamat, A. M., Flaig, T. W., Grossman, H. B., Konety, B. R., Lamm, D. L., O’Donnell, M. A., Uchio, E., Efstathiou, J. A., & Taylor, J. A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.58 · Cited by 255
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
McMurray, J. J. V., Krum, H., Abraham, W. T., Dickstein, K., Køber, L., Desai, A. S., Solomon, S. D., Greenlaw, N., Ali, M. A., Chiang, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514859 · Cited by 254
Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction
Givertz, M. M., Stevenson, L. W., Costanzo, M. R., Bourge, R. C., Bauman, J. G., Ginn, G., & Abraham, W. T. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.010 · Cited by 253
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 251
Irbesartan in Patients with Atrial Fibrillation
The ACTIVE I Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008816 · Cited by 251
Self-citation
2024 Clinical practice guidelines for Chronic heart failure
Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 251
The Primary and Secondary Prevention of Coronary Artery Disease
Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M. D., O’Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., & Harrington, R. A. (2008) · CHEST Journal · doi:10.1378/chest.08-0685 · Cited by 250
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure
Roig, E. S. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1740 · Cited by 250
Factors contributing to the hospitalization of patients with congestive heart failure.
Chin, M. H., & Goldman, L. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.4.643 · Cited by 250
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies
MacMahon, S. W., & Collins, R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04017-4 · Cited by 249
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
Wong, M., Staszewsky, L. I., Latini, R., Barlera, S., Volpi, A., Chiang, Y., Benza, R. L., Gottlieb, S. O., Kleemann, T., Rosconi, F., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02063-6 · Cited by 249
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.
Fentzke, R. C., Korcarz, C. E., Lang, R. M., Lin, H., & Leiden, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2950 · Cited by 249
ACE Inhibitor Use in Patients With Myocardial Infarction
Latini, R., Maggioni, A. P., Flather, M. D., Sleight, P., & Tognoni, G. (1995) · Circulation · doi:10.1161/01.cir.92.10.3132 · Cited by 249
Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD)
Vermes, E., Ducharme, A., Bourassa, M. G., Lessard, M., White, M., & Tardif, J.-C. (2003) · Circulation · doi:10.1161/01.cir.0000054611.89228.92 · Cited by 248
The Renin-Angiotensin-Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States
Brewster, U. C., Perazella, M. A., & Setaro, J. F. (2003) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200307000-00003 · Cited by 247
Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
Testani, J. M., Kimmel, S. E., Dries, D. L., & Coca, S. G. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.963256 · Cited by 246
Non-Compliance and Knowledge of Prescribed Medication in Elderly Patients with Heart Failure
Cline, C. M. J., Björck‐Linné, A. K., Israelsson, B., Willenheimer, R. B., & Erhardt, L. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00014-8 · Cited by 246
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities
Gajarsa, J. J., & Kloner, R. A. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9181-7 · Cited by 245
Angiotensin-converting enzyme in innate and adaptive immunity
Bernstein, K. E., Khan, Z., Giani, J. F., Cao, D., Bernstein, E. A., & Shen, X. Z. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.15 · Cited by 245
C-Reactive Protein as a Predictor of Improvement and Readmission in Heart Failure
Alonso-Martínez, J. L., Llorente‐Diez, B., Agara, M. E., Preciado, F. O., Urbieta-Echezarreta, M. A., & Arencibia, C. G. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00021-1 · Cited by 243
Chronic Heart Failure: Contemporary Diagnosis and Management
Ramani, G. V., Uber, P. A., & Mehra, M. R. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0494 · Cited by 243
Functional and Biochemical Analysis of Angiotensin II–Forming Pathways in the Human Heart
Wolny, A. C., Clozel, J., Rein, J., Mory, P., Vogt, P. R., Turino, M., Kiowski, W., & Fischli, W. (1997) · Circulation Research · doi:10.1161/01.res.80.2.219 · Cited by 243
Knowledge, patterns of care, and outcomes of care for generalists and specialists
Harrold, L. R., Field, T. S., & Gurwitz, J. H. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.08168.x · Cited by 242
Initiating Sacubitril/Valsartan (LCZ696) in Heart Failure: Results of TITRATION, a Double-Blind, Randomized Comparison of Two Uptitration Regimens
Senni, M., McMurray, J. J. V., Wachter, R., McIntyre, H. F., Reyes, A., Majerčák, I., Andreka, P. G., Shehova-Yankova, N. S., Anand, I. S., Yılmaz, M. B., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.548 · Cited by 241
Is the Prognosis of Heart Failure Improving?
Cleland, J. G. F., Gemmell, I., Khand, A. U., & Boddy, A. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00032-x · Cited by 241
Use of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death
Rector, T. S., Tschumperlin, L. K., Kubo, S. H., Bank, A. J., Francis, G. S., McDonald, K., Keeler, C. A., & Silver, M. A. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90025-x · Cited by 240
Heart Failure Survival Among Older Adults in the United States
Croft, J. B., Giles, W. H., Pollard, R. A., Keenan, N. L., Casper, M. L., & Anda, R. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.505 · Cited by 240
Rationale and Design of the GISSI Heart Failure Trial: A Large Trial to Assess the Effects of n-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Diagnosis and Treatment of Heart Failure Based on Left Ventricular Systolic or Diastolic Dysfunction
Gaasch, W. H. (1994) · JAMA · doi:10.1001/jama.1994.03510400062033 · Cited by 240
Heart failure disease management: a critical review
Rich, M. W. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90026-x · Cited by 240
Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
Beldhuis, I. E., Lam, C. S. P., Testani, J. M., Voors, A. A., Spall, H. G. C. V., ter Maaten, J. M., & Damman, K. (2022) · Circulation · doi:10.1161/circulationaha.121.052792 · Cited by 239
Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis
Burnett, H., Earley, A., Voors, A. A., Senni, M., McMurray, J. J. V., Deschaseaux, C., & Cope, S. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003529 · Cited by 238
Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
Philbin, E. F., Rocco, T. A., Lindenmuth, N. W., Ulrich, K., & Jenkins, P. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00601-x · Cited by 238
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Telli, M. L., Witteles, R. M., Fisher, G. A., & Srinivas, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn168 · Cited by 237
Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review
Tea, K., Yusuf, S., Pfeffer, M. A., Køber, L., Hall, A. S., Pogue, J. M., Latini, R., & Collins, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11138-x · Cited by 237
His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block
Arnold, A. D., Shun-Shin, M. J., Keene, D., Howard, J. P., Sohaib, S. M. A., Wright, I. J., Cole, G. D., Qureshi, N. A., Lefroy, D. C., Koa‐Wing, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.073 · Cited by 236
Exploration of the Precision of Classifying Sudden Cardiac Death
Pratt, C. M., Greenway, P. S., Schoenfeld, M. H., Hibben, M. L., & Reiffel, J. A. (1996) · Circulation · doi:10.1161/01.cir.93.3.519 · Cited by 236
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
Arnold, J. M. O., Yusuf, S., Young, J. B., Mathew, J., Johnstone, D. E., Avezum, Á., Lonn, E., Pogue, J., & Bosch, J. (2003) · Circulation · doi:10.1161/01.cir.0000054165.93055.42 · Cited by 236

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks